当前位置: 首页 > 详情页

Mild hypothermia therapy attenuates early BBB leakage in acute ischaemic stroke

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China [2]Beijing Key Laboratory of Hypoxia Conditioning Translational Medicine, Beijing, China [3]Center of Stroke, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China [4]Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, China
出处:
ISSN:

关键词: Acute ischaemic stroke brain-blood barrier therapeutic hypothermia microvessels F-actin

摘要:
Reperfusion therapy inevitably leads to brain-blood barrier (BBB) disruption and promotes damage despite its benefits for acute ischaemic stroke (AIS). An effective brain cytoprotective treatment is still needed as an adjunct to reperfusion therapy. Here, we explore the potential benefits of therapeutic hypothermia (HT) in attenuating early BBB leakage and improving neurological outcomes. Mild HT was induced during the early and peri-recanalization stages in a mouse model of transient middle cerebral artery occlusion and reperfusion (tMCAO/R). The results showed that mild HT attenuated early BBB leakage in AIS, decreased the infarction volume, and improved functional outcomes. RNA sequencing data of the microvessels indicated that HT decreased the transcription of the actin polymerization-related pathway. We further discovered that HT attenuated the ROCK1/MLC pathway, leading to a decrease in the polymerization of G-actin to F-actin. Arachidonic acid (AA), a known structural ROCK agonist, partially counteracted the protective effects of HT in the tMCAO/R model. Our study highlights the importance of early vascular protection during reperfusion and provides a new strategy for attenuating early BBB leakage by HT treatment for ischaemic stroke.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 2 区 内分泌学与代谢 2 区 血液学 2 区 神经科学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 内分泌学与代谢 2 区 血液学 2 区 神经科学
JCR分区:
出版当年[2022]版:
Q1 ENDOCRINOLOGY & METABOLISM Q1 HEMATOLOGY Q1 NEUROSCIENCES
最新[2023]版:
Q1 ENDOCRINOLOGY & METABOLISM Q1 HEMATOLOGY Q1 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China [2]Beijing Key Laboratory of Hypoxia Conditioning Translational Medicine, Beijing, China
通讯作者:
通讯机构: [1]Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China [2]Beijing Key Laboratory of Hypoxia Conditioning Translational Medicine, Beijing, China [3]Center of Stroke, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China [*1]Xuanwu Hospital, No. 45, Changchun Street, Xuanwu Hospital, Beijing 100053, China [*2]Xuanwu Hospital, 45 Changchun St., Beijing 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院